# Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen

Study · id `cardio:ct-nct03672110` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03672110](<https://clinicaltrials.gov/study/NCT03672110>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03672110

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

## Technical summary

Registry record NCT03672110. Randomized; no masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2020-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT03672110, source copy `cardio:ctgov-nct03672110-2022-08-03`, retrieved 2026-10-26)
- Start date: 2014-09 (registry gives no type) (ClinicalTrials.gov record NCT03672110, source copy `cardio:ctgov-nct03672110-2022-08-03`, retrieved 2026-10-26)
- Primary completion: 2020-02 (actual) (ClinicalTrials.gov record NCT03672110, source copy `cardio:ctgov-nct03672110-2022-08-03`, retrieved 2026-10-26)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT03672110, source copy `cardio:ctgov-nct03672110-2022-08-03`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT03672110, source copy `cardio:ctgov-nct03672110-2022-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03672110-2022-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
- Acronym: S&L
- Condition: Renal Failure
- Condition: Renal Insufficiency
- Condition: Renal Disease
- Condition: Renal Insufficiency, Chronic
- Intervention (Drug): Advagraf
- Lead sponsor: Technische Universität Dresden
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: dfef1a969c9bea3ff93256308ea611db06421109ab50ea296e66303393452a27
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
